1. Home
  2. ARDX vs PRG Comparison

ARDX vs PRG Comparison

Compare ARDX & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.98

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo PROG Holdings Inc.

PRG

PROG Holdings Inc.

HOLD

Current Price

$29.56

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
PRG
Founded
2007
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ARDX
PRG
Price
$5.98
$29.56
Analyst Decision
Strong Buy
Buy
Analyst Count
10
6
Target Price
$10.65
$35.00
AVG Volume (30 Days)
2.7M
430.9K
Earning Date
10-30-2025
10-22-2025
Dividend Yield
N/A
1.76%
EPS Growth
N/A
10.59
EPS
N/A
3.96
Revenue
$398,234,000.00
$2,507,179,000.00
Revenue This Year
$22.71
$1.32
Revenue Next Year
$27.81
$0.64
P/E Ratio
N/A
$7.46
Revenue Growth
58.12
3.71
52 Week Low
$3.21
$23.50
52 Week High
$6.78
$48.82

Technical Indicators

Market Signals
Indicator
ARDX
PRG
Relative Strength Index (RSI) 57.69 53.19
Support Level $5.49 $27.48
Resistance Level $6.02 $30.54
Average True Range (ATR) 0.28 1.03
MACD 0.01 0.37
Stochastic Oscillator 75.00 77.87

Price Performance

Historical Comparison
ARDX
PRG

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About PRG PROG Holdings Inc.

PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.

Share on Social Networks: